ORGANOGENESIS HOLDINGS INC. Property, Plant and Equipment, Gross
ORGANOGENESIS HOLDINGS INC. (ORGO) had Property, Plant and Equipment, Gross of $165.07 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-26
- 2025-12-31: Property, Plant and Equipment, Gross $165.07M.
- 2025-09-30: Property, Plant and Equipment, Gross $134.62M.
- 2025-06-30: Property, Plant and Equipment, Gross $131.77M.
- 2025-03-31: Property, Plant and Equipment, Gross $128.12M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $165.07M 10-K · filed 2026-02-26 |
| 2025-09-30 | $134.62M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $131.77M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $128.12M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $140.19M 10-K · filed 2026-02-26 |
| 2024-09-30 | $144.43M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $145.70M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $130.60M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $130.35M 10-K · filed 2025-02-27 |
| 2023-09-30 | $128.33M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $118.94M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $115.59M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $99.70M 10-K · filed 2024-02-29 |
| 2022-09-30 | $98.56M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $96.05M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $93.74M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $89.43M 10-K · filed 2023-03-01 |
| 2021-09-30 | $102.69M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $98.72M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $88.77M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $87.81M 10-K · filed 2022-03-01 |
| 2020-09-30 | $86.97M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $86.16M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $83.69M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $82.77M 10-K · filed 2021-03-16 |
| 2019-09-30 | $81.13M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $79.89M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $79.55M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $79.10M 10-K · filed 2020-03-09 |
| 2017-12-31 | $78.52M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |